FDA Greenlights Magic Mushrooms for Drug Trials to Treat Depression
The US Federal Drug Administration has given the go-ahead to a London-based startup to begin drug trials using psilocybin, the main active psychedelic compound in magic mushrooms, to treat depression. The startup, Compass Pathways, funded […]